The interconnection between different trimesters of pregnancy and the risk of COVID-19

Keywords: COVID-19, morbidity, pregnancy, SARS-CoV-2, infections

Abstract

this article summarizes the issues within the framework of the scientific discussion regarding the interconnection between different trimesters of pregnancy and the risk of COVID-19. The main objective of this study is to assess the impact of the risk of COVID-19 from the time of infection, namely from different trimesters, to understand the risks of complications at different stages of pregnancy, to assess the impact of the trimester of infection with COVID-19 on the progression of the disease, to determine whether the frequency of progression of the disease of COVID-19 increases with increasing gestational age. Through a detailed study of literature sources, systematization and approaches to solving the problem, it was found that the outbreak of the COVID-19 pandemic in the United States resulted in more than 97 million infections and more than 1.06 million deaths. Approximately 182,000 cases were reported among pregnant women, with 285 maternal deaths. Normal pregnancy is mainly associated with a decrease in functional residual lung capacity by 20-30% and an increase in oxygen consumption by 20%. As a result, lower respiratory tract infections are poorly tolerated, especially in the third trimester. The relevance of the study of this pathology lies in the fact that pregnant patients have a higher risk of infection with coronavirus 2 (SARS-CoV-2) in a severe or critical form compared to non-pregnant women of the same age. In addition, this disparity was exacerbated during the Delta variant surge. An increased risk of adverse outcomes for newborns and mothers is associated with a severe course of COVID-19 during pregnancy. However, little is known about the influence of the time of infection during pregnancy on such risks, so it can lead to errors in the treatment of such pregnant women, which prevents timely, correct treatment and prevention. Methods were used in the study of bibliographic and content analysis of the literature, comparative approach and synthesis, as well as semantic grouping regarding the features of the relationship between different trimesters of pregnancy and the risk of COVID-19. All documents found on various official websites were analyzed and the collected information was compared and grouped. The article presents the results of studies that showed that the frequency of progression of the disease of COVID-19 does not differ from the trimester of diagnosis. The disease of moderate, severe or critical degree develops in almost 10% of pregnant women infected with the SARS-CoV-2 virus. These results highlight the importance of preventive measures, including vaccination against COVID-19 before or as early as possible during pregnancy. As vaccination rates among pregnant women increase, further research is needed to understand disease progression. Similarly, disease severity and progression should be further studied in the context of the development of medical therapy and the evolution of new SARS-CoV-2 variants and recurrent infection. Therefore, further research is needed to obtain patient-centered and cost-effectiveness data. The results of this study may be of interest to primary care physicians, gynecologists, and therapists.

References

Abdullahi, H., Elnahas, A., & Konje, J. C. (2021). Seasonal influenza during pregnancy. European journal of obstetrics, gynecology, and reproductive biology, 258, 235–239. https://doi.org/10.1016/j.ejogrb.2021.01.005

Adhikari, E. H., SoRelle, J. A., McIntire, D. D., & Spong, C. Y. (2022). Increasing severity of COVID-19 in pregnancy with Delta (B.1.617.2) variant surge. American journal of obstetrics and gynecology, 226(1), 149–151. https://doi.org/10.1016/j.ajog.2021.09.008

American College of Obstetricians and Gynecologists. Practice advisory: COVID-19 vaccination considerations for obstetric-gynecologic care. 2021. https://acog.org/clinical/clinical-guidance/practice-advisory/articles/2020/12/covid-19-vaccination-considerations-for-obstetric-gynecologic-care.

Centers for Disease Control and Prevention. COVID data tracker. 2021. https://covid.cdc.gov/covid-data-tracker/#datatracker-home

Centers for Disease Control and Prevention. COVID data tracker - pregnant population. 2021. https://covid.cdc.gov/covid-data-tracker/#pregnant-population.

Centers for Disease Control and Prevention. COVID Data Tracker – COVID-19 vaccination among pregnant people aged 18-49 years overall, by race/ethnicity, and date reported to CDC - Vaccine Safety Datalink,* United States. 2021. https://covid.cdc.gov/covid-data-tracker/#vaccinations-pregnant-women.

Convalescent Plasma for the Treatment of COVID-19: Perspectives of the National Institutes of Health COVID-19 Treatment Guidelines Panel. Annals of internal medicine, 174(1), 93–95. https://doi.org/10.7326/M20-6448

Combes, A. J., Courau, T., Kuhn, N. F., Hu, K. H., Ray, A., Chen, W. S., Chew, N. W., Cleary, S. J., Kushnoor, D., Reeder, G. C., Shen, A., Tsui, J., Hiam-Galvez, K. J., Muñoz-Sandoval, P., Zhu, W. S., Lee, D. S., Sun, Y., You, R., Magnen, M., Rodriguez, L., … Krummel, M. F. (2021). Global absence and targeting of protective immune states in severe COVID-19. Nature, 591(7848), 124–130. https://doi.org/10.1038/s41586-021-03234-7

Delahoy, M. J., Whitaker, M., O'Halloran, A., Chai, S. J., Kirley, P. D., Alden, N., Kawasaki, B., Meek, J., Yousey-Hindes, K., Anderson, E. J., Openo, K. P., Monroe, M. L., Ryan, P. A., Fox, K., Kim, S., Lynfield, R., Siebman, S., Davis, S. S., Sosin, D. M., Barney, G., … COVID-NET Surveillance Team (2020). Characteristics and Maternal and Birth Outcomes of Hospitalized Pregnant Women with Laboratory-Confirmed COVID-19 - COVID-NET, 13 States, March 1-August 22, 2020. MMWR. Morbidity and mortality weekly report, 69(38), 1347–1354. https://doi.org/10.15585/mmwr.mm6938e1

DeSisto, C. L., Wallace, B., Simeone, R. M., Polen, K., Ko, J. Y., Meaney-Delman, D., & Ellington, S. R. (2021). Risk for Stillbirth Among Women With and Without COVID-19 at Delivery Hospitalization - United States, March 2020-September 2021. MMWR. Morbidity and mortality weekly report, 70(47), 1640–1645. https://doi.org/10.15585/mmwr.mm7047e1

Duryea, E. L., & Sheffield, J. S. (2021). Influenza: threat to maternal health. Obstetrics and gynecology clinics of North America, 42(2), 355–362. https://doi.org/10.1016/j.ogc.2015.01.009

Feikin, D. R., Higdon, M. M., Abu-Raddad, L. J., Andrews, N., Araos, R., Goldberg, Y., Groome, M. J., Huppert, A., O'Brien, K. L., Smith, P. G., Wilder-Smith, A., Zeger, S., Deloria Knoll, M., & Patel, M. K. (2022). Duration of effectiveness of vaccines against SARS-CoV-2 infection and COVID-19 disease: results of a systematic review and meta-regression. Lancet (London, England), 399(10328), 924–944. https://doi.org/10.1016/S0140-6736(22)00152-0

Johns Hopkins Univeristy and Medicine. 2021. Accessed March 1, 2022. https://coronavirus.jhu.edu/map.html.

Juan, J., Gil, M. M., Rong, Z., Zhang, Y., Yang, H., & Poon, L. C. (2020). Effect of coronavirus disease 2019 (COVID-19) on maternal, perinatal and neonatal outcome: systematic review. Ultrasound in obstetrics & gynecology : the official journal of the International Society of Ultrasound in Obstetrics and Gynecology, 56(1), 15–27. https://doi.org/10.1002/uog.22088

Khan, D. S. A., Pirzada, A. N., Ali, A., Salam, R. A., Das, J. K., & Lassi, Z. S. (2021). The Differences in Clinical Presentation, Management, and Prognosis of Laboratory-Confirmed COVID-19 between Pregnant and Non-Pregnant Women: A Systematic Review and Meta-Analysis. International journal of environmental research and public health, 18(11), 5613. https://doi.org/10.3390/ijerph18115613

Male V. (2022). SARS-CoV-2 infection and COVID-19 vaccination in pregnancy. Nature reviews. Immunology, 22(5), 277–282. https://doi.org/10.1038/s41577-022-00703-6

Metz, T. D., Clifton, R. G., Hughes, B. L., Sandoval, G., Saade, G. R., Grobman, W. A., Manuck, T. A., Miodovnik, M., Sowles, A., Clark, K., Gyamfi-Bannerman, C., Mendez-Figueroa, H., Sehdev, H. M., Rouse, D. J., Tita, A. T. N., Bailit, J., Costantine, M. M., Simhan, H. N., Macones, G. A., & Eunice Kennedy Shriver National Institute of Child Health and Human Development (NICHD) Maternal-Fetal Medicine Units (MFMU) Network (2021). Disease Severity and Perinatal Outcomes of Pregnant Patients With Coronavirus Disease 2019 (COVID-19). Obstetrics and gynecology, 137(4), 571–580. https://doi.org/10.1097/AOG.0000000000004339

Mertz, D., Geraci, J., Winkup, J., Gessner, B. D., Ortiz, J. R., & Loeb, M. (2020). Pregnancy as a risk factor for severe outcomes from influenza virus infection: A systematic review and meta-analysis of observational studies. Vaccine, 35(4), 521–528. https://doi.org/10.1016/j.vaccine.2016.12.012

Nana, M., & Nelson-Piercy, C. (2021). COVID-19 in pregnancy. Clinical medicine (London, England), 21(5), e446–e450. https://doi.org/10.7861/clinmed.2021-0503

National Institutes of Health.COVID-19 treatment guidelines. 2021. https://www.covid19treatmentguidelines.nih.gov/how-to-cite/.

Pau, A. K., Aberg, J., Baker, J., Belperio, P. S., Coopersmith, C., Crew, P., Grund, B., Gulick, R. M., Harrison, C., Kim, A., Lane, H. C., Masur, H., Sheikh, V., Singh, K., Yazdany, J., Tebas, P., & National Institutes of Health COVID-19 Treatment Guidelines Panel (2021).

Rasmussen, S. A., & Jamieson, D. J. (2022). COVID-19 and Pregnancy. Infectious disease clinics of North America, 36(2), 423–433. https://doi.org/10.1016/j.idc.2022.01.002

Seasely, A. R., Blanchard, C. T., Arora, N., Battarbee, A. N., Casey, B. M., Dionne-Odom, J., Leal, S. M., Jr, Moates, D. B., Sinkey, R. G., Szychowski, J. M., Tita, A. T., Subramaniam, A., & CWRH's COVID-19 Working Group (2022). Maternal and Perinatal Outcomes Associated With the Omicron Variant of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Infection. Obstetrics and gynecology, 140(2), 262–265. https://doi.org/10.1097/AOG.0000000000004849

Sculli, M. A., Formoso, G., & Sciacca, L. (2021). COVID-19 vaccination in pregnant and lactating diabetic women. Nutrition, metabolism, and cardiovascular diseases : NMCD, 31(7), 2151–2155. https://doi.org/10.1016/j.numecd.2021.04.012

Published
2023-06-16
How to Cite
1.
Shumilina T, Tsmur O. The interconnection between different trimesters of pregnancy and the risk of COVID-19. USMYJ [Internet]. 2023Jun.16 [cited 2026Mar.21];139(2):90-8. Available from: https://mmj.nmuofficial.com/index.php/journal/article/view/310